Advertisement

Evaluation of the ITV-margin and variables affecting bladder and mesorectal deformation during long course neoadjuvant radiotherapy for rectal cancer

      ABSTRACT

      Internal target volume (ITV) margins were estimated by evaluating the movement of mesorectum and bladder during neoadjuvant long-course radiation therapy (RT) for rectal cancer. In this prospective study, 23 patients with rectal cancer had planning CT (pCT) and weekly cone beam CT (CBCT) in supine position during preoperative long-course RT. Mesorectal wall motion was analyzed based on the coordinates of the most anterior, posterior, left and right points on the pCT and CBCT. Overlap volume (OV) between the pCT bladder and CBCT mesorectum was generated. Variables that might affect relative bladder volume (ratio of CBCT to pCT bladder volumes), anterior mesorectal wall position, and OV were studied. ITV margins were also calculated. In females, smaller OV and less movement of the upper anterior mesorectal wall were identified, suggesting smaller ITV margins might be required compared to males. The relative bladder volume did not change significantly over time and was correlated with OV: the larger the relative bladder volume, the less the OV. ITV margin of 0.8 to 1.1 cm in right-left direction is satisfactory. Posteriorly, only 8 to 9 mm margin is required for upper and mid rectal regions but double of this is required for inferior third. Anteriorly, 1.3 cm margin is adequate for lower and mid rectal regions and 2.4 cm is required superiorly. An anisotropic ITV expansion of clinical target volume (CTV) for rectal cancer radiotherapy contouring provides a robust method to encompass the deformation of bladder and mesorectum. The ITV margin should take into account sex and distance from the anal verge.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Medical Dosimetry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. National Comprehensive Cancer Network. (2021). Rectal Cancer. Version 1. 2021. Available at: https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf (Accessed: April 1 2021).

        • Abdalmassih M.
        • Sivananthan G.
        • Raizman Z.
        • et al.
        Prognostic markers ofrecurrence and survival in rectal cancer treated with neoadjuvant che-moradiotherapy and surgery.
        Colorectal Cancer. 2018; 7: CRC02
        • Fleming F.L.
        • Pahlman L.
        • Monson J.R.
        Neoadjuvant therapy in rectal cancer.
        Dis Colon Rectum. 2011; 54: 901-912
        • Rödel C.
        • Martus P.
        • Papadoupolos T.
        • et al.
        Prognostic Significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
        J. Clin. Oncol. 2005; 23: 8688-8696
        • Burbach J.M.
        • Verkooijen H.M.
        • Intven M.
        • et al.
        RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): Study protocol for a randomized controlled trial.
        Trials. 2015; 22: 58https://doi.org/10.1186/s13063-015-0586-4
        • Garcia-Aguila J.
        • Patil S.
        • Kim J.K.
        • et al.
        Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
        J. Clin. Oncol. 2020; 38: 4008
        • Jakobsen A.
        • Ploen J.
        • Vuong T.
        • et al.
        Dose effect relationship in chemoradiotherapy for locally advanced rectal cancer: A randomized trial comparing two radiation doses.
        Int J Radiat Oncol Biol Phys. 2012; 86: 949-954
        • Burbach J.P.
        • den Harder A.M.
        • Intven M.
        • et al.
        Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis.
        Radiother Oncol. 2014; 113: 1-9
        • Nijkamp J.
        • de Jong R.
        • Sonke J.J.
        • et al.
        Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients.
        Radiother Oncol. 2009; 92: 202-209
        • Myerson R.J.
        • Garofalo M.C.
        • Naga I.E.
        • et al.
        Elective clinical target volume for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas.
        Int J Radit Oncol Biol Phys. 2009; 74: 824-830
      2. ICRU, Report 62. (1999). Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), ICRU Report 62. Bethesda, Maryland: International Commission on Radiation Units and Measurements.

        • Chong I.
        • Hawkins M.
        • Hansen V.
        • et al.
        Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computer tomography.
        Int J Radiat Oncol Biol Phys. 2011; 81: e431-e438
        • Daly M.E.
        • Murphy J.D.
        • Mok E.
        • et al.
        Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy?.
        Pract Radiat Oncol. 2011; 1: 85-94
        • Nijkamp J.
        • Swellengrebel M.
        • Hollmann B.
        • et al.
        Repeat CT assessed CTV variation and PTV margins or short- and long-course pre-operative RT of rectal cancer.
        Radiother Oncol. 2012; 102: 399-405
        • Brierley J.D.
        • Dawson L.A.
        • Sampson E.
        • et al.
        Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum.
        Int J Radiatino Oncology Biol Phys. 2011; 80: 97-102
        • Nuyttens J.J.
        • Robertson J.
        • Yan D.
        • et al.
        The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment.
        Radiat Oncol Biol Phys. 2002; 53: 497-503
        • Allal A.
        • Bischoff S.
        • Nouet P.
        Impact of the ‘‘belly board” device on treatment reproducibility in preoperative radiotherapy.
        Strahlenther Onkol. 2001; 178: 259-262
        • Nijkamp J.
        • de Jong R.
        • Sonke J.-J.
        • et al.
        Target volume shape variation during irradiation of rectal cancer patients in supine position: Comparison with prone position.
        Radiother Oncol. 2009; 93: 285-292
        • de Jong R.
        • Lutkenhaus L.
        • van Wieringen N.
        • et al.
        Plan selection strategy for rectum cancer patients: An interobserver study to assess clinical feasability.
        Radiother Oncol. 2016; 120: 207-211
        • Rosa C.
        • Caravatta L.
        • Tommaso M.D.
        • et al.
        Cone beam computer tomography for organ motion evaluation in locally advanced rectal cancer patients.
        La radiologia medica. 2020; 126: 147-154
        • Alickikus Z.A.
        • Kuru A.
        • Aydin B.
        • et al.
        The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy.
        J. Radiat. Res. 2020; 61: 335-342
        • Mahadevan V.
        The anatomy of the rectum and anal canal.
        Surgery (Oxford). 2011; 21: 5-10
        • van Herk M.
        • Remeijer P.
        • Rasch C.
        • et al.
        The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy.
        Int J Radiat Oncol Biol Phys. 2000; 47: 1121-1135
        • Kachnic L.A.
        • Winter K.
        • Myerson R.J.
        • et al.
        RTOG 0529: A phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycinC for the reduction of acute morbidity in carcinoma of th anal canal.
        Int J Radiat Oncol Biol Phys. 2013; 1: 27-33
        • Valentini V.
        • Gambacorta M.A.
        • Barbaro B.
        • et al.
        International consensus guidelines on Clinical Target Volume delineation in rectal cancer.
        Radiother Oncol. 2016; 47: 195-201